GloveOn COATS Handy Pack

COATS® (an acronym for Colloidal Oatmeal System) is a patented and unique nitrile glove technology. COATS® utilises the powerful benefits of all-natural oats, an FDA-recognised skin protectant, as a coating that forms a natural, moisturising barrier between the glove and skin. This acts as a preventative measure against skin irritation, and eliminates uncomfortable and irritating conditions experienced when wearing normal gloves. Users who suffer from dry and itchy skin due to frequent hand washing and glove usage can now rely on COATS® to soothe and nurture the skin, and protect their hands while they work.

Reorder Code	Size
CTS157SS	Small
CTS157MM	Medium
CTS157LL	Large

Glove Properties	Measurement (mm)
Length	≥230
Thickness at Palm (centre of Palm)	0.07 ± 0.02
Thickness at Finger (13mm ± 3mm from tip)	0.09 ± 0.02

Physical Properties	Before Ageing	After Ageing
Tensile Strength (MPa)	≥18	≥16
Elongation (%)	≥500	≥400

Inspection Levels and AQL	Inspection Level	AQL
Watertightness	G1	1.5
Physical Dimensions	S2	4.0
Tensile Strength	S2	4.0
Visual Inspection (Major)	S4	2.5
Visual Inspection (Minor)	S4	4.0
Particulate Residue	N=5	≤2mg/glove

Packaging
Configuration	200 gloves per box for XS to L 180 gloves per box for XL 10 boxes per carton

Regulatory Compliance
Regulations	ARTG 164563 FDA 510(k) MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 EU 2016/425

International Standards
Standards	ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN ISO 374-1 (Type B) EN 374 part 2, 4 & 5 EN 16523-1 EN 420 EN 455 part 1, 2, 3 & 4 EN 1186 EN 13130 CEN/TS 14234 ISO 10993 part 5 & 10 HACCP International Certified

Manufacturing Accreditations
Accreditations	ISO 9001 ISO 13485 EN ISO 13485

Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05-Test Report PN 145460)	Minimum Breakthrough Detection Time (minutes)
Carmustine (BCNU), 3.3mg/ml (3,300ppm)	16.2
Cisplatin, 1.0mg/ml (1,000ppm)	>240
Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm)	>240
Dacarbazine (DTIC), 10.0mg/ml (10,000ppm)	>240
Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm)	>240
Etoposide (Toposar), 20.0mg/ml (20,000ppm)	>240
Fluorouracil, 50.0mg/ml (50,000ppm)	>240
Methotrexate, 25.0mg/ml (25,000ppm)	>240
Mitomycin C, 0.5mg/ml (500ppm)	>240
Paclitaxel (Taxol), 6.0mg/ml (6,000ppm)	>240
Thiotepa, 10.0mg/ml (10,000ppm)	28.4
Vincristine Sulfate, 1.0mg/ml (1,000ppm)	>240
WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Celeste nitrile glove at 16.2 minutes and 28.4 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision.